DimebonŽ - HORIZON | Print |  Email

HORIZON Phase III trial of Dimebon

Trial status: Completed

Sponsor: Medivation, Inc. in collaboration with Pfizer

Results:  Negative results;  No cognitive benefit.


 
< Prev   Next >

To comment on this article or contact HDDW for any other reason, please email us.

© 2007 HDDW. All Rights Reserved.